INTRODUCTION
============

Lower urinary tract symptoms (LUTS) refer to a combination of urinary symptoms associated with storage and/or voiding disturbance. Diseases such as spinal cord injury, prostate enlargement, and prostate cancer cause LUTS, and LUTS are also associated with cardiovascular risk factors, such as hypertension, dyslipidemia, and diabetes \[[@b1-jpmph-52-3-147]-[@b3-jpmph-52-3-147]\]. The prevalence of LUTS in Asian populations aged \>60 years is \>60% \[[@b4-jpmph-52-3-147]\], and the incidence of prostate diseases, which are the main cause of LUTS in Korea, is increasing \[[@b5-jpmph-52-3-147]\]. LUTS increase the public health burden by reducing quality of life (QoL) \[[@b6-jpmph-52-3-147],[@b7-jpmph-52-3-147]\] and increasing the risk of falls and fracture \[[@b8-jpmph-52-3-147],[@b9-jpmph-52-3-147]\].

Many studies have investigated associations between obesity and LUTS, but the results have been inconsistent. In addition, the relevance of LUTS in underweight subjects has not been fully evaluated. Some previous studies have reported an association between obesity and LUTS \[[@b10-jpmph-52-3-147]-[@b12-jpmph-52-3-147]\], while others did not \[[@b13-jpmph-52-3-147],[@b14-jpmph-52-3-147]\]. Additionally, most studies did not evaluate the relationship between underweight and LUTS. As LUTS and obesity are both strongly affected by lifestyle factors, such as diet, physical activity (PA), alcohol consumption, and smoking \[[@b10-jpmph-52-3-147],[@b12-jpmph-52-3-147],[@b15-jpmph-52-3-147]\], a study with sufficient consideration of potential confounders is needed. The aim of this study was to evaluate the relationship between body mass index (BMI) and LUTS in Korean males aged 50 years or over. Specifically, we aimed to evaluate whether the relationship between BMI and LUTS was linear or non-linear, and to investigate the relationships of BMI categories based on World Health Organization cut-off points with LUTS.

METHODS
=======

Survey Design
-------------

This study was conducted on males aged ≥50 years who participated in the 2011 Korean Community Health Survey (KCHS). The KCHS is a nationwide, cross-sectional survey carried out by the Korean Centers of Disease Control and Prevention \[[@b16-jpmph-52-3-147]\]. The target population for the KCHS is adults aged ≥19 years who live within the jurisdiction of a community health center. The stratum was divided into 2 stages according to administrative units (*dong, eup*, and *myeon*) and housing units (apartments and houses), and the smallest administrative district units (*tong, ban*, and *ri*) were selected as the primary sampling unit of the stratum through probability proportionate sampling. Sample households were extracted through systemic sampling of the primary sampling units. Information was gathered through face-to-face interviews conducted by a trained interviewer. A total of 229 226 participants were enrolled in the 2011 KCHS, of whom 52 018 were males ≥50 years of age. BMI was missing for 1888 participants (3.6%), the International Prostate Symptom Score (IPSS) questionnaire was missing for 736 participants (1.4%), smoking status was missing for 8 participants (\<0.1%), alcohol consumption was missing for 38 participants (0.1%), PA was missing for 183 participants (0.4%), marital status was missing for 37 participants (0.1%), household income was missing for 4049 participants (7.8%), education level was missing for 139 participants (0.3%), hypertension medication was missing for 23 participants (\<0.1%), diabetes medication was missing for 35 participants (0.1%), and dyslipidemia medication was missing for 192 participants (0.4%). In the final analysis, 45 476 participants (87.4%) without missing values were included.

Lower Urinary Tract Symptoms and Body Mass Index
------------------------------------------------

LUTS severity was assessed using the Korean version of the IPSS questionnaire \[[@b17-jpmph-52-3-147]\], and dichotomized as severe (IPSS \>19) and non-severe (IPSS ≤19) \[[@b18-jpmph-52-3-147]\]. The IPSS questionnaire consists of 7 questions, on the following topics: frequency, urgency, nocturia, incomplete emptying, intermittency, weak stream, and straining to void. The scale of all items ranges from 0 to 5, and the higher the score, the more frequent the symptom. The IPSS storage subscore is the sum of the scores for the questions on frequency, urgency, and nocturia. The IPSS voiding subscore is the sum of the scores for the questions on incomplete emptying, intermittency, weak stream, and straining to void. BMI was calculated from self-reported body weight and height. BMI was divided into 6 categories: BMI\<18.5, 18.5≤BMI\<23.0, 23.0≤BMI\< 25.0, 25.0≤BMI\< 27.5, 27.5≤BMI\<30.0, and BMI≥30.0 kg/m^2^ \[[@b19-jpmph-52-3-147]\].

Covariates
----------

Information on lifestyle factors, socioeconomic status, and comorbidities were collected through interviews. Alcohol consumption was coded as none, at least 1 standard drink per week, and less than 1 standard drink per week. Participants were classified by smoking status as current smokers, ex-smokers, and non-smokers. PA was dichotomized based on whether participants engaged in moderate or vigorous PA. Moderate PA was defined as moderate-intensity PA (e.g., swimming at a slow pace, table tennis, badminton, tennis doubles) for more than 5 days per week for 30 minutes or more. Vigorous PA was defined as vigorous-intensity PA (e.g., swimming at a fast pace, climbing, cycling, squash, tennis singles) for more than 3 days per week for 20 minutes or more. Marital status was coded as living with a partner or not. Household income was measured as self-reported monthly household income or annual household income and was divided into quartiles. Education level was categorized into primary school or no education and secondary or higher education. The presence of comorbidities, including hypertension, diabetes, dyslipidemia, and prostate enlargement, was determined by whether participants took medication for the disorder.

Statistical Analysis
--------------------

The weighted baseline characteristics of the study population are expressed as mean±standard deviation or proportion (%). Linear regression analyses were performed to examine trends in the covariates across the BMI categories.

Prevalence rate ratios (PRRs) according to BMI categories were estimated by multivariate Poisson regression, using *svyglm* from the survey package in R to account for the stratified multistage sampling design of the KCHS \[[@b20-jpmph-52-3-147]\]. Four models were fit. Model 1 was crude, model 2 was adjusted for age, model 3 was additionally adjusted for socioeconomic status and lifestyle, and model 4 was additionally adjusted for comorbidities. The age-adjusted B-spline Poisson regression model was fitted using knots at the 5th, 50th, and 95th percentiles of BMI. Non-linearity was evaluated by comparing the goodness of fit of the B-spline regression model with the linear regression model.

All results were weighted according to the sampling weights provided by the 2011 KCHS. Significance was set at a *p*-value \<0.05. All analyses were performed using R version 3.5.1 (<https://cran.r-project.org/bin/windows/base/old/3.5.1/>).

RESULTS
=======

The weighted baseline characteristics of the study population according to BMI category are presented in [Table 1](#t1-jpmph-52-3-147){ref-type="table"}. Participants with higher BMIs were younger, had lower total IPSS and IPSS subscores, had a higher household income, more frequently resided with a partner, had more education, were less likely to be smokers, were more likely to be drinkers, engaged in more PA, and had higher prevalence rates of hypertension, diabetes, and dyslipidemia.

[Table 2](#t2-jpmph-52-3-147){ref-type="table"} presents PRRs for severe LUTS according to BMI categories. A U-shaped relationship was detected between BMI and severe LUTS. The BMI category of 23.0-24.9 kg/m^2^ was used as the reference. In model 4, the PRR for a BMI \<18.5 kg/m^2^ was 1.65 (95% confidence interval \[CI\], 1.35 to 2.02), that for a BMI of 18.5-22.9 kg/m^2^ was 1.25 (95% CI, 1.09 to 1.44), that for a BMI of 25.0-27.4 kg/m^2^ was 1.20 (95% CI, 1.00 to 1.45), that for a BMI of 27.5-29.9 kg/m^2^ was 1.11 (95% CI, 0.83 to 1.47), and that for a BMI ≥ 30.0 kg/m^2^ was 1.85 (95% CI, 1.18 to 2.88).

[Table 3](#t3-jpmph-52-3-147){ref-type="table"} presents the results of a sensitivity analysis excluding subjects with prostate enlargement. The U-shaped relationship between BMI and severe LUTS was more prominent. In model 4, the PRR for a BMI \<18.5 kg/m^2^ was 2.06 (95% CI, 1.57 to 2.70), that for a BMI of 18.5-22.9 kg/m^2^ was 1.42 (95% CI, 1.17 to 1.73), that for a BMI of 25.0-27.4 kg/m^2^ was 1.32 (95% CI, 1.02 to 1.71), that for a BMI of 27.5-29.9 kg/m^2^ was 1.26 (95% CI, 0.85 to 1.88), and that for a BMI ≥30.0 kg/m^2^ was 2.07 (95% CI, 1.14 to 3.73).

[Figure 1](#f1-jpmph-52-3-147){ref-type="fig"} shows the age-adjusted relationship between BMI and total IPSS. Data points below the 0.5th percentile and above the 99.5th percentile were removed as outliers. A U-shaped relationship was observed between BMI and IPSS (p for non-linearity \<0.001). When the BMI was 24.0 kg/m^2^, the mean total IPSS was the lowest, at 4.85. The relationship between BMI and the IPSS subscores was also U-shaped (data not shown).

DISCUSSION
==========

In this large-scale cross-sectional study using a nationally representative sample of Korean adults, a U-shaped relationship was detected between BMI and LUTS, and the prevalence was lowest at a BMI of 23.0-24.9 kg/m^2^. The sensitivity analysis revealed that this relationship was more prominent in subjects without prostate enlargement. These results were independent of age, lifestyle, and comorbidities. This is the first study to show a non-linear relationship between BMI and LUTS.

In previous studies on the associations between BMI and LUTS, a U-shaped association was not fully evaluated and the association was inconsistent. Most previous studies evaluated linear associations between BMI and LUTS \[[@b10-jpmph-52-3-147],[@b11-jpmph-52-3-147],[@b13-jpmph-52-3-147]\] or did not evaluate the association between underweight and LUTS \[[@b12-jpmph-52-3-147],[@b14-jpmph-52-3-147]\]. Chen et al. \[[@b10-jpmph-52-3-147]\] reported that a high BMI was associated with a large prostate volume and a high IPSS in the Chinese population. Bhindi et al. \[[@b13-jpmph-52-3-147]\] reported that BMI was not related to the IPSS, but was related to prostate volume. In the Third National Health and Nutrition Examination Survey, Rohrmann et al. \[[@b14-jpmph-52-3-147]\] determined that current BMI was not associated with LUTS, but subjects who were obese and overweight at the age of 25 years had a low prevalence of LUTS. Associations between high BMI and LUTS have been reported in prospective studies. In the Boston Area Community Health Survey, Maserejian et al. \[[@b11-jpmph-52-3-147]\] reported that a high BMI was associated with symptom progression. In the Osteoporotic Fractures in Men Study, Parsons et al. \[[@b12-jpmph-52-3-147]\] reported a higher incidence of LUTS in subjects with overweight and obesity. In our study, a significant U-shaped relationship was observed between BMI and LUTS. Similar to our results, Smith et al. \[[@b21-jpmph-52-3-147]\] reported a U-shaped relationship, with a high prevalence of severe LUTS found in individuals with obesity and underweight. However, no statistically significant differences were observed in the prevalence of LUTS between underweight and normal-weight participants because there were few underweight participants. In a study based on the 2012 KCHS, the relationship between BMI and overactive bladder was also U-shaped \[[@b22-jpmph-52-3-147]\].

The association between obesity and LUTS can be explained by hormonal changes. First, obesity induces insulin resistance, and the increased serum insulin elevates sympathetic nerve tone, leading to overactive bladder and prostate enlargement \[[@b23-jpmph-52-3-147]\]. In addition, the androgen receptor located in the prostate smooth muscle binds insulin-like growth factor, so insulin can induce smooth muscle contraction \[[@b24-jpmph-52-3-147]\]. Second, changes in sex hormones can exacerbate LUTS. Increased adipose tissue in obese subjects increases serum estrogen levels \[[@b25-jpmph-52-3-147]\]. Estrogen is involved in the pathogenesis of prostate cancer, one of the causes of LUTS. In animal studies, estrogen has been found to act on estrogen receptor alpha, leading to prostate cancer \[[@b26-jpmph-52-3-147]\]. In addition, higher testosterone-to-estrogen enzyme conversion activity resulted in a higher incidence of prostate cancer in a genome-wide association study \[[@b27-jpmph-52-3-147]\].

The mechanism for the relationship between underweight and LUTS is unclear, but a possible explanation is as follows. First, BMI reflects not only adiposity, but also lean body mass, and underweight is associated with sarcopenia \[[@b28-jpmph-52-3-147]\]. Degradation of bladder function by sarcopenia or decreased muscle strength may be associated with voiding symptoms. In addition, the percentage of body fat may be high even in a subject with a low BMI because the percentage of muscle decreases with age \[[@b29-jpmph-52-3-147]\]. LUTS can be induced by increased adipose tissue in both underweight and obesity. Second, the relationship between underweight and LUTS may reflect reverse causation. Poor QoL leads to weight loss \[[@b30-jpmph-52-3-147]\], and LUTS deteriorates several indicators of QoL, such as sleep quality, depression, mobility, and self-rated health \[[@b31-jpmph-52-3-147]\].

The limitations of this study are as follows. First, we only used BMI as an index of obesity, but the relationships of underweight and obesity with LUTS have also been explored through other anthropometric methods, such as fat distribution, waist circumference, and the waist-hip ratio index. Second, BMI was calculated from self-reported body weight and height. In a study based on the 2016 KCHS, the correlation between measured BMI and BMI calculated by self-reported body weight and height was 0.86 at ages ≥60 years, which was lower than at other ages \[[@b32-jpmph-52-3-147]\]. Therefore, further studies using accurately measured data are needed.

In conclusion, a U-shaped relationship was detected between BMI and LUTS in Korean males, and this relationship was significant even after adjusting for lifestyle, socioeconomic status, and comorbidities. These results suggest that both underweight and obesity can contribute to LUTS. It also suggests that healthcare providers caring for LUTS patients need to pay attention to the issues of underweight and obesity. However, the role of underweight is unclear in the etiology of LUTS development. Further studies are needed on the mechanisms underlying this relationship.
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###### 

Weighted baseline characteristics of the study population according to BMI categories^[1](#tfn1-jpmph-52-3-147){ref-type="table-fn"}^

  Characteristics                                                      BMI (kg/m^2^)   *p* for trend                                                   
  -------------------------------------------------------------------- --------------- --------------- ----------- ----------- ----------- ----------- ---------
  Unweighted sample size (n)                                           1830            18 989          13 352      8356        2379        570         
  Percentage of total sample                                           2.9             40.1            30.6        19.7        5.5         1.3         
  Severe LUTS                                                          13.9            5.4             3.4         3.8         3.3         6.0         \<0.001
  Age                                                                  69.4±0.4        62.1±0.1        60.5±0.1    59.6±0.1    58.9±0.2    58.6±0.5    \<0.001
  IPSS                                                                                                                                                 
   Total                                                               8.84±0.30       4.88±0.07       4.03±0.07   3.96±0.09   3.89±0.15   4.33±0.38   \<0.001
   Voiding                                                             4.83±0.19       2.65±0.04       2.16±0.04   2.11±0.06   2.01±0.10   2.24±0.25   \<0.001
   Storage                                                             4.01±0.13       2.23±0.03       1.87±0.03   1.85±0.04   1.88±0.07   2.08±0.16   \<0.001
  Smoking history                                                                                                                                      \<0.001
   Never                                                               15.0            19.2            21.2        20.0        20.6        18.6        
   Ex-smoker                                                           41.7            41.5            46.5        49.2        49.3        51.2        
   Current smoker                                                      43.4            39.3            32.3        30.8        30.1        30.2        
   Physical activity^[2](#tfn2-jpmph-52-3-147){ref-type="table-fn"}^   16.2            24.1            27.6        26.6        25.5        22.7        \<0.001
  Alcohol consumption (standard drink/d)                                                                                                               \<0.001
   Non-drinker                                                         52.7            35.6            31.2        29.3        30.7        33.9        
   \<1                                                                 18.9            28.8            30.2        29.4        26.4        21.7        
   ≥1                                                                  28.4            35.6            38.5        41.3        42.9        44.4        
  Living with partner                                                  82.6            86.6            89.8        89.9        89.9        90.3        \<0.001
  Household income                                                                                                                                     \<0.001
   Q1                                                                  52.3            28.9            23.0        20.6        22.2        19.6        
   Q2                                                                  19.7            25.0            25.1        24.6        22.1        24.1        
   Q3                                                                  16.1            27.1            28.4        29.5        32.5        33.5        
   Q4                                                                  11.9            19.1            23.6        25.3        23.2        22.8        
  Higher than primary education                                        56.6            76.3            82.1        83.3        82.6        80.3        \<0.001
  Hypertension                                                         19.8            24.6            31.8        39.9        46.6        60.0        \<0.001
  Diabetes                                                             8.4             11.2            13.1        15.3        17.3        23.8        \<0.001
  Dyslipidemia                                                         1.8             5.1             7.7         10.2        11.6        14.7        \<0.001
  Prostate enlargement                                                 12.0            7.7             7.5         7.4         7.3         8.7         0.076

Values are presented as % or mean±standard deviation.

BMI, body mass index; LUTS, lower urinary tract symptoms; IPSS, International Prostate Symptom Score.

All means, standard deviations, and percentages were calculated by using sampling weights.

Thirty minutes of moderate physical activity on 5 days or more per week.

###### 

PRRs for LUTS according to BMI categories

                                                            BMI (kg/m^2^)                                                                                      
  --------------------------------------------------------- ------------------- ------------------- ------------------ ------------------- ------------------- -------------------
  Model 1^[1](#tfn3-jpmph-52-3-147){ref-type="table-fn"}^   4.03 (3.31, 4.91)   1.57 (1.36, 1.80)   1.00 (reference)   1.09 (0.90, 1.33)   0.96 (0.72, 1.29)   1.76 (1.14, 2.72)
  Model 2^[2](#tfn4-jpmph-52-3-147){ref-type="table-fn"}^   1.69 (1.38, 2.06)   1.26 (1.10, 1.45)   1.00 (reference)   1.24 (1.02, 1.49)   1.17 (0.88, 1.56)   2.06 (1.30, 3.26)
  Model 3^[3](#tfn5-jpmph-52-3-147){ref-type="table-fn"}^   1.51 (1.23, 1.84)   1.20 (1.05, 1.38)   1.00 (reference)   1.25 (1.03, 1.50)   1.17 (0.88, 1.55)   2.04 (1.31, 3.18)
  Model 4^[4](#tfn6-jpmph-52-3-147){ref-type="table-fn"}^   1.65 (1.35, 2.02)   1.25 (1.09, 1.44)   1.00 (reference)   1.20 (1.00, 1.45)   1.11 (0.83, 1.47)   1.85 (1.18, 2.88)

Values are presented as PRR (95% confidence interval).

PRR, prevalence rate ratio; LUTS, lower urinary tract symptoms; BMI, body mass index.

The crude model.

Adjusted for age.

Additionally adjusted for lifestyle factors (physical activity, alcohol consumption, and smoking status) and variables reflecting socioeconomic status (marital status, household income, and education level).

Additionally adjusted for comorbidities (hypertension, diabetes, and dyslipidemia).

###### 

PRRs for LUTS according to categorized BMI, excluding participants with prostate enlargement

                                                             BMI (kg/m^2^)                                                                                      
  ---------------------------------------------------------- ------------------- ------------------- ------------------ ------------------- ------------------- -------------------
  Model 1^[1](#tfn7-jpmph-52-3-147){ref-type="table-fn"}^    5.29 (4.07, 6.87)   1.80 (1.48, 2.19)   1.00 (reference)   1.21 (0.93, 1.57)   1.09 (0.73, 1.63)   2.01 (1.12, 3.60)
  Model 2^[2](#tfn8-jpmph-52-3-147){ref-type="table-fn"}^    2.18 (1.67, 2.84)   1.47 (1.20, 1.79)   1.00 (reference)   1.36 (1.05, 1.77)   1.32 (0.89, 1.97)   2.24 (1.22, 4.11)
  Model 3^[3](#tfn9-jpmph-52-3-147){ref-type="table-fn"}^    1.91 (1.46, 2.49)   1.37 (1.13, 1.67)   1.00 (reference)   1.37 (1.05, 1.77)   1.32 (0.89, 1.95)   2.25 (1.25, 4.06)
  Model 4^[4](#tfn10-jpmph-52-3-147){ref-type="table-fn"}^   2.06 (1.57, 2.70)   1.42 (1.17, 1.73)   1.00 (reference)   1.32 (1.02, 1.71)   1.26 (0.85, 1.88)   2.07 (1.14, 3.73)

Values are presented as PRR (95% confidence interval).

PRR, prevalence rate ratio; LUTS, lower urinary tract symptoms; BMI, body mass index.

The crude model.

Adjusted for age.

Additionally adjusted for lifestyle factors (physical activity, alcohol consumption, and smoking status) and variables reflecting socioeconomic status (marital status, household income, and education level).

Additionally adjusted for comorbidities (hypertension, diabetes, and dyslipidemia).
